CW December 2002
Volume 11Issue Number 12 December 2002 ISSN 10593802 Low Molecular Weight Heparins Prevent Thrombosis in Cancer PatientsLife threatening blood clot formation is prevented and treated by drugs such as heparin and warfarin. Low molecular weight heparins have been synthesized and are found to be more effective in reducing the long-term risk of blood clots in cancer patients when compared with the standard treatment with warfarin.
Go to Previous Page Go to Next Page Source & Additional Reading 44th Annual Meeting of the American Society of Hematology. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW December 2002Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
